Table 2.
Relationship between KIAA0513 expression and clinicopathological characteristics in PDAC
| Variables | Number | KIAA0513 expression | P-value | |
|---|---|---|---|---|
|
| ||||
| Low | High | |||
| Age | 165 | |||
| < 60 years | 65 | 13 | 52 | 0.403 |
| > 60 years | 100 | 15 | 85 | |
| Gender | ||||
| Male | 72 | 11 | 61 | 0.610 |
| Female | 93 | 17 | 76 | |
| Tumor location | ||||
| Head | 89 | 19 | 70 | 0.105 |
| Body/tail | 76 | 9 | 67 | |
| Serum ca19-9 | ||||
| < 37 U/ml | 29 | 17 | 12 | < 0.001 |
| ≥ 37 U/ml | 136 | 11 | 125 | |
| Grade | ||||
| Well | 45 | 12 | 33 | 0.042 |
| Moderate/poor | 120 | 16 | 104 | |
| Lymph status | ||||
| Absent | 59 | 5 | 54 | 0.030 |
| Present | 106 | 23 | 83 | |
| Tnm stage | ||||
| I-II | 46 | 15 | 31 | 0.001 |
| III-IV | 119 | 13 | 106 | |